Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4726
Coherus Oncology
CHRS
$185M
| $2.97M | ﹤0.01% |
2,857,208
+13,760
| +0.5% | +$18.9K |
|
|
PPL
4727
PUT
PPL Corp
PPL
$27.1B
| $2.97M | ﹤0.01% |
89,800
+300
| +0.3% | +$9.18K |
|
4728
LeMaitre Vascular
LMAT
$1.88B
| $2.97M | ﹤0.01% |
31,940
-42,724
| -57% | -$3.7M |
|
4729
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.41B
| $2.97M | ﹤0.01% |
86,052
-133,602
| -61% | -$4.3M |
|
4730
CALL
Mattel
MAT
$4.29B
| $2.96M | ﹤0.01% |
155,600
-18,900
| -11% | -$348K |
|
4731
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
| $2.96M | ﹤0.01% |
+101,998
| New | +$2.93M |
|
|
ITCI
4732
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.96M | ﹤0.01% |
40,500
-20,800
| -34% | -$1.56M |
|
4733
PUT
Structure Therapeutics
GPCR
$3.87B
| $2.96M | ﹤0.01% |
67,500
-25,900
| -28% | -$1M |
|
4734
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
| $2.96M | ﹤0.01% |
+43,709
| New | +$2.81M |
|
|
NXDR
4735
Nextdoor Holdings
NXDR
$998M
| $2.96M | ﹤0.01% |
1,193,042
-409,060
| -26% | -$1.05M |
|
4736
CALL
OGE Energy
OGE
$9.81B
| $2.96M | ﹤0.01% |
72,100
-100
| -0.1% | -$3.88K |
|
4737
CALL
Ascendis Pharma A/S
ASND
$16.3B
| $2.96M | ﹤0.01% |
19,800
-12,800
| -39% | -$1.73M |
|
4738
PUT
NEOS S&P 500 High Income ETF
SPYI
$11.4B
| $2.96M | ﹤0.01% |
57,700
+55,500
| +2,523% | +$2.79M |
|
|
OSG
4739
CALL
Octave Specialty Group
OSG
$221M
| $2.95M | ﹤0.01% |
263,600
+143,300
| +119% | +$1.68M |
|
4740
PUT
Commault Systems
CVLT
$6.1B
| $2.95M | ﹤0.01% |
19,200
+10,100
| +111% | +$1.42M |
|
4741
iShares MSCI Turkey ETF
TUR
$222M
| $2.95M | ﹤0.01% |
+81,183
| New | +$3.19M |
|
4742
CALL
Visteon
VC
$2.89B
| $2.95M | ﹤0.01% |
31,000
+25,900
| +508% | +$2.63M |
|
4743
PUT
Progress Software
PRGS
$1.79B
| $2.95M | ﹤0.01% |
43,800
+7,400
| +20% | +$424K |
|
4744
PUT
Dine Brands
DIN
$447M
| $2.95M | ﹤0.01% |
94,400
+27,200
| +40% | +$876K |
|
4745
PUT
Beazer Homes USA
BZH
$872M
| $2.95M | ﹤0.01% |
86,200
+33,200
| +63% | +$1.02M |
|
|
KEEL
4746
CALL
Keel Infrastructure Corp
KEEL
$2.17B
| $2.94M | ﹤0.01% |
1,395,100
+296,000
| +27% | +$686K |
|
4747
CALL
Sable Offshore Corp
SOC
$796M
| $2.94M | ﹤0.01% |
+124,500
| New | +$2.24M |
|
4748
US Physical Therapy
USPH
$1.21B
| $2.94M | ﹤0.01% |
34,737
-11,745
| -25% | -$1.04M |
|
4749
CALL
National Fuel Gas
NFG
$7.79B
| $2.94M | ﹤0.01% |
48,500
-15,300
| -24% | -$895K |
|
4750
PUT
Insperity
NSP
$1.99B
| $2.94M | ﹤0.01% |
33,400
+12,900
| +63% | +$1.19M |
|
Similar funds
Ken Griffin's Q3 2024 Portfolio in Review
As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Ken Griffin opened 1,614 new positions and closed 1,610 in Q3 2024.
- Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.